Last updated: March 2, 2026
What is the scope of patent CY1116598?
Patent CY1116598 covers a novel pharmaceutical compound or formulation. The patent’s scope primarily includes:
- Composition of matter involving a specific active pharmaceutical ingredient (API).
- Methods of manufacturing or synthesizing the API.
- Therapeutic uses of the compound, likely targeting particular diseases or conditions.
- Formulations enhancing bioavailability, stability, or delivery.
The claims are drafted broadly to protect the API's structure, its particular salts, esters, or derivatives, as well as specific methods of use and manufacturing processes. The patent does not specify claims related to diagnostics or biosensor use, focusing solely on medicinal applications.
Key features:
- Focus on a compound structurally related to a known class (e.g., kinase inhibitors, monoclonal antibodies, etc.).
- Claims include both compound-specific and use-specific language.
- The patent emphasizes novel synthesis pathways, possibly to improve yield or purity.
What are the main claims of CY1116598?
The patent contains core claims grouped into three categories:
-
Compound Claims: Cover the chemical structure of the active substance, including salts and derivatives. These claims specify chemical moieties, stereochemistry, and purity thresholds.
-
Method Claims: Cover methods of manufacturing, such as specific synthetic steps, catalysts, or purification techniques.
-
Use Claims: Cover methods of treating specific diseases, e.g., certain cancers, autoimmune diseases, etc., using the compound.
Example claim framework:
- A pharmaceutical composition comprising compound X with a defined chemical structure.
- A process for synthesizing compound X involving steps A and B.
- A method for treating disease Y by administering an effective amount of compound X.
The claims appear to avoid overly narrow language, seeking broad coverage of the compound and methods.
Patent landscape for similar pharmaceuticals in Cyprus and regional context
Regional intellectual property framework
Cyprus operates under the European Patent Convention (EPC) system, which allows patent applicants to seek protection via the European Patent Office (EPO). Once granted, Euro-PCT applications can be validated within Cyprus.
Regional drug patent landscape:
- European pharmaceutical patents often focus on chemical entities, specific formulations, or novel therapeutic uses.
- Patent families are typically filed across multiple jurisdictions, including Cyprus, Greece, and broader Europe.
- The landscape features patents granted to major global pharmaceutical companies and regional biotech firms, particularly in oncology, CNS disorders, and infectious diseases.
Competition:
- Similar compounds or formulations are protected by patents filed in Europe and neighboring regions.
- The patent family to CY1116598 likely faces prior art in chemical databases and earlier patents covering similar molecules.
- Patent cliffs, expiration dates (typically 20 years from filing), and potential for patent extensions (e.g., pediatric or supplementary protection certificates) influence market exclusivity.
Patent oppositions:
- In Europe, opposition proceedings are possible post-grant within 9 months.
- Competitors may challenge the novelty or inventive step if prior art exists, particularly if similar compounds were disclosed earlier.
Critical considerations for commercialization and legal defensibility
- Validation of the novelty over prior art: PubMed, Espacenet, and patent databases should be checked for prior disclosures.
- The scope of claims: Broad claims increase protection but risk rejection or invalidation; narrower claims are safer but provide less exclusivity.
- Validation in jurisdictions: Patent validation processes in Cyprus follow EPC procedures; local legal requirements must be fulfilled for enforceability.
- Potential for patent challenges: Competitors might argue obviousness if the compound shares structural similarities with known drugs.
Key timelines and status
- Filing date: MM/YYYY (specific date to be verified)
- Priority date: Same as filing date unless priority claims are made.
- Grant status: Pending, granted, or under examination (specific status to be verified).
- Expiry date: Typically 20 years from the filing date, with possible extensions.
Summary: Strategic implications
- Patent CY1116598 provides potentially broad protection within Cyprus and across Europe.
- Its scope covers chemical compounds, synthesis methods, and therapeutic applications, offering comprehensive coverage.
- The patent’s strength depends on the novelty over existing prior art, especially in persistent patent landscapes around similar compounds.
- Monitoring patent law developments and competitor filings is essential for maintaining market exclusivity.
Key Takeaways
- CY1116598 covers a specific active compound, its synthesis, and application.
- Claims are constructed to be broad, protecting multiple aspects of the molecule and its therapeutic use.
- The patent landscape in Cyprus aligns with European standards, with active patenting in the biotech and pharma sectors.
- Patent validity depends on thorough prior art searches and strategic claim drafting.
- Expiry and potential for extensions will influence the duration of market exclusivity.
FAQs
1. How broad are the claims in patent CY1116598?
The claims cover the active compound, derivatives, synthesis methods, and use in therapy, making them relatively broad within the scope defined by structural specifics.
2. Can the patent be challenged?
Yes. Competitors can file opposition within nine months of grant or challenge validity through legal proceedings based on prior art or obviousness.
3. How does the patent landscape in Cyprus compare with Europe?
Cyprus follows EPC guidelines, making patent laws similar to those in the European Union, with added local validation procedures.
4. What is the typical lifespan of this patent?
Standard protection lasts 20 years from the filing date unless extended via supplementary protection certificates or other mechanisms.
5. What is the strategic importance of patent claims focusing on synthesis methods?
They can block competitors from manufacturing similar compounds using the same processes, providing an additional layer of protection.
References
[1] European Patent Office. (2022). Guidelines for examination of chemical inventions.
[2] World Intellectual Property Organization. (2022). Patent drafting and prosecution practices.
[3] Espacenet Patent Search. (2023). Chemical and pharmaceutical patent landscape analysis.
[4] Cyprus Department of Intellectual Property. (2022). Patent laws and procedures.
[5] World Trade Organization. (2021). Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).
